112290 — YCchem Co Balance Sheet
0.000.00%
- KR₩221bn
- KR₩261bn
- KR₩70bn
- 22
- 11
- 59
- 17
Annual balance sheet for YCchem Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,053 | 899 | 29,784 | 27,796 | 23,856 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5,228 | 6,266 | 7,971 | 6,020 | 7,924 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 16,210 | 18,188 | 50,573 | 47,463 | 43,549 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 57,879 | 58,726 | 60,762 | 63,879 | 67,160 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 78,501 | 81,711 | 116,088 | 119,569 | 116,280 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 44,785 | 39,106 | 35,566 | 41,643 | 50,569 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 63,359 | 53,998 | 48,541 | 59,083 | 71,780 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 15,142 | 27,713 | 67,547 | 60,486 | 44,500 |
| Total Liabilities & Shareholders' Equity | 78,501 | 81,711 | 116,088 | 119,569 | 116,280 |
| Total Common Shares Outstanding |